169 related articles for article (PubMed ID: 1942540)
41. Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann's Thrombasthenia.
Zahran AM; Saad K; Elsayh KI; Alblihed MA; Embaby M
Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):565-571. PubMed ID: 28161816
[TBL] [Abstract][Full Text] [Related]
42. Rapid heterozygote detection in Glanzmann's thrombasthenia.
Sharp WJ; Khanduri UD; Christie BS
Br J Haematol; 1998 Apr; 101(1):66-9. PubMed ID: 9576183
[TBL] [Abstract][Full Text] [Related]
43. Classification of Glanzmann's thrombasthenia based on the intracellular transport pathway of GPIIb-IIIa.
Kato A; Yamamoto K; Aoki N
Thromb Haemost; 1992 Nov; 68(5):615-6. PubMed ID: 1455408
[No Abstract] [Full Text] [Related]
44. Clinical spectrum of Glanzmann's thrombasthenia.
Badhe BA; Jayanthi S; Datta T
Indian J Pathol Microbiol; 2000 Jul; 43(3):297-302. PubMed ID: 11218676
[TBL] [Abstract][Full Text] [Related]
45. Normal expression of the adhesive structure Mo-1 on monocytes from patients with Glanzmann's thrombasthenia.
Setiadi H; Antoine C; Wautier JL
J Mal Vasc; 1991; 16(1):30-1. PubMed ID: 2010702
[TBL] [Abstract][Full Text] [Related]
46. [Analysis of the GPIIb and GPIIIa genes in patients with Glanzmann's thrombasthenia].
Yasunaga M; Ryo R; Adachi M; Sugano W; Yoshida A; Nakayama K; Saigo K; Yasunaga K; Yamaguchi N
Rinsho Ketsueki; 1992 Feb; 33(2):133-8. PubMed ID: 1635160
[TBL] [Abstract][Full Text] [Related]
47. Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann's thrombasthenia.
Bray PF; Shuman MA
Blood; 1990 Feb; 75(4):881-8. PubMed ID: 1967954
[TBL] [Abstract][Full Text] [Related]
48. An exon 28 mutation resulting in alternative splicing of the glycoprotein IIb transcript and Glanzmann's thrombasthenia.
Iwamoto S; Nishiumi E; Kajii E; Ikemoto S
Blood; 1994 Feb; 83(4):1017-23. PubMed ID: 8111043
[TBL] [Abstract][Full Text] [Related]
49. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization.
Bellucci S; Damaj G; Boval B; Rocha V; Devergie A; Yacoub-Agha I; Garderet L; Ribaud P; Traineau R; Socié G; Gluckman E
Bone Marrow Transplant; 2000 Feb; 25(3):327-30. PubMed ID: 10673707
[TBL] [Abstract][Full Text] [Related]
50. A novel Ser123Pro substitution in the MIDAS domain of integrin 3 associated with variant Glanzmann's thrombasthenia in an Indian patient.
Nair S; Ghosh K; Shetty S; Mohanty D
Haematologica; 2004 Dec; 89(12):1529-30. PubMed ID: 15590407
[TBL] [Abstract][Full Text] [Related]
51. Periodontal management of Glanzmann's thrombasthenia: report of 3 cases.
Kantarci A; Cebeci I; Firatli E; Atamer T; Tuncer O
J Periodontol; 1996 Aug; 67(8):816-20. PubMed ID: 8866321
[TBL] [Abstract][Full Text] [Related]
52. Demonstration of a marked reduction in the amount of GPIIb in most type II patients with Glanzmann's thrombasthenia.
Tomiyama Y; Kashiwagi H; Kosugi S; Shiraga M; Kinoshita S; Kanayama Y; Kurata Y; Matsuzawa Y
Br J Haematol; 1994 May; 87(1):119-24. PubMed ID: 7947235
[TBL] [Abstract][Full Text] [Related]
53. Glanzmann's thrombasthenia with mild von Willebrand's disease.
Nounou R; Spence D
J Clin Pathol; 1993 Dec; 46(12):1134-6. PubMed ID: 8282841
[TBL] [Abstract][Full Text] [Related]
54. Glanzmann's thrombasthenia: an overview.
Kannan M; Saxena R
Clin Appl Thromb Hemost; 2009; 15(2):152-65. PubMed ID: 18930954
[TBL] [Abstract][Full Text] [Related]
55. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
[TBL] [Abstract][Full Text] [Related]
56. [Glanzmann thrombasthenia--a defect in the surface membrane of platelets].
Cieslar P; Dyr J; Suttnar J; Matousová O; Friedmann B
Vnitr Lek; 1990 Aug; 36(8):729-37. PubMed ID: 2136456
[TBL] [Abstract][Full Text] [Related]
57. A novel ELISA for diagnosis of Glanzmann's thrombasthenia and the heterozygote carriers.
Lobo V; Shetty S; Kulkarni B; Butera D; Magalhaes GS; Ghosh K
Ann Hematol; 2012 Jun; 91(6):917-21. PubMed ID: 22183252
[TBL] [Abstract][Full Text] [Related]
58. Glanzmann's thrombasthenia.
Tullu MS; Dixit PS; Nair SB; Kamat JR; Vaswani RK; Shetty SD; Pawar AR
Indian J Pediatr; 2001 Jun; 68(6):563-6. PubMed ID: 11450390
[TBL] [Abstract][Full Text] [Related]
59. Diagnosis of heterozygotes in Glanzmann's thrombasthenia.
Stormorken H; Gogstad GO; Solum NO; Pande H
Thromb Haemost; 1982 Oct; 48(2):217-21. PubMed ID: 6217584
[TBL] [Abstract][Full Text] [Related]
60. Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis.
McGregor JL; Clemetson KJ; James E; Capitanio A; Greenland T; Lüscher EF; Dechavanne M
Eur J Biochem; 1981 May; 116(2):379-88. PubMed ID: 7195813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
